Clinical Hours: Mon-Fri, 8AM - 3PM(905) 493-5700
1885 Glenanna Road, Suite 220, Pickering, ON, L1V 6R6
Perioral dermatitis is a common facial skin condition causing small papules and pustules around the mouth, nose, and eyes, often triggered by topical corticosteroids.
Perioral dermatitis is a common inflammatory facial dermatosis characterised by grouped small papules, papulopustules, and mild scaling in a distribution around the mouth, nose, and eyes. Despite its name, perioral dermatitis is not a true form of dermatitis (eczema) but rather a distinct entity that shares clinical features with both rosacea and acne.
The condition predominantly affects women between the ages of 20 and 45, although it can occur in men and children. Perioral dermatitis is frequently misdiagnosed and inappropriately treated with topical corticosteroids, which paradoxically worsen and perpetuate the condition. Recognition of this pattern is essential for correct diagnosis and effective management.
The exact pathogenesis of perioral dermatitis is not fully understood, but the condition is strongly associated with the use of topical corticosteroids on the face. Application of even mild potency corticosteroids to the perioral or periocular area can trigger the eruption, and continued use leads to a cycle of temporary improvement followed by progressively worsening flares upon discontinuation.
Additional factors associated with perioral dermatitis include:
A role for follicular fusiform bacteria and Demodex mites has been proposed but not definitively established. The condition is not contagious and is not caused by poor hygiene.
Perioral dermatitis presents with characteristic clinical features that aid in distinguishing it from other facial dermatoses:
The eruption may be confined to a single area (perioral only) or involve multiple facial zones simultaneously. In children, a granulomatous variant may occur, presenting as flesh-coloured to yellowish papules rather than inflammatory pustules. The condition typically follows a chronic, relapsing course if the underlying triggers are not identified and addressed.
Perioral dermatitis is diagnosed clinically based on the characteristic morphology and distribution of the eruption. A thorough history, including the use of topical corticosteroids and skincare products, is essential. The diagnosis does not typically require a biopsy, although histopathological examination may be performed in atypical cases and reveals a perifollicular lymphohistiocytic infiltrate with or without granulomatous features.
The differential diagnosis includes rosacea (which tends to affect the central face with flushing and telangiectasia), acne (which presents with comedones), contact dermatitis (which shows eczematous changes with vesiculation), and seborrheic dermatitis (which involves the nasolabial folds and scalp with greasy scaling). A specialist dermatology consultation is valuable for confirming the diagnosis, particularly when the presentation overlaps with these conditions.
The management of perioral dermatitis centres on discontinuation of the offending agent and initiation of appropriate medical therapy. Treatment is typically effective, although the initial withdrawal phase from topical corticosteroids can be challenging.
The first and most critical step in management is the complete discontinuation of all topical corticosteroids on the face. Abrupt cessation may lead to a temporary flare (rebound dermatitis) that can be significant, and patients should be counselled to expect this worsening before improvement begins. In cases of severe steroid dependence, a gradual taper using progressively lower potency formulations may be considered, although complete cessation remains the goal.
Topical metronidazole (0.75% to 1%) is the most widely used first-line topical treatment for perioral dermatitis. Topical azelaic acid and topical erythromycin are effective alternatives. Topical calcineurin inhibitors (pimecrolimus, tacrolimus) may be used in selected cases, particularly for periocular involvement, although these should be applied with caution as they may occasionally exacerbate the condition. Topical ivermectin has also demonstrated benefit in some patients.
Oral antibiotics are indicated for moderate to severe perioral dermatitis or cases that do not respond adequately to topical therapy alone. Tetracycline-class antibiotics (doxycycline, minocycline) are the standard oral treatment, used at anti-inflammatory rather than antimicrobial doses. A typical course lasts six to twelve weeks, with gradual tapering once the eruption has cleared. Oral erythromycin is an alternative for patients in whom tetracyclines are contraindicated, such as pregnant women and children. All oral and topical therapies are coordinated through a structured prescription management programme.
Simplification of the skincare routine is an important component of management. Patients are advised to use gentle, fragrance-free cleansers and lightweight, non-occlusive moisturisers. Switching to a non-fluorinated toothpaste may be beneficial. Physical (mineral) sunscreens containing zinc oxide or titanium dioxide are generally better tolerated than chemical sunscreen formulations in affected patients.
Dermatological assessment is recommended for any persistent or recurring facial eruption that does not respond to standard skincare measures, or that worsens with the use of over-the-counter topical treatments. Specialist evaluation is particularly important when topical corticosteroids have been used on the face, as early intervention can prevent the cycle of steroid dependence and rebound flaring.
A referral from a family physician is the standard pathway to access specialist dermatology care. Dr. Maksym Breslavets at the Centre for Medical and Surgical Dermatology provides specialist evaluation and management of perioral dermatitis, including differentiation from other facial dermatoses and structured treatment programmes for corticosteroid withdrawal.
Your feedback helps us improve our condition information
A physician referral is required to access our medical services. Contact your primary care provider to begin the referral process.